Acumen Pharmaceuticals, Inc. (ABOS) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ABOS Hot Sheet
Join SI Premium – FREE
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q2 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35).
For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- JPMorgan Downgrades Woolworths Holdings Ltd (WHL:SJ) to Underweight
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
